Mode
Text Size
Log in / Sign up
Phase 4 N=43 Randomized Single-blind Treatment

Outcomes of Neuraxial Anesthetic Technique on the Trial of Labor After Cesarean (TOLAC)

Labor Pain · Complications; Cesarean Section · Pregnancy

Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Jul 2018
Primary outcome: Primary: Number of Participants With Vaginal Birth After Cesarean (VBAC) — 12; 22 Participants

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Epidural anesthesia (Drug); Combined spinal and epidural anesthesia (Drug)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
The University of Texas Health Science Center, Houston
Primary completion
Apr 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Vaginal Birth After Cesarean (VBAC)
12; 22
SECONDARY
Success of Analgesia as Indicated by Pain Score Assessed by Visual Analogue Scale (VAS)
3.5; 2.53
SECONDARY
Success of Analgesia as Indicated by Pain Score Assessed by Visual Analogue Scale (VAS)
3.5; 2.53
SECONDARY
Success of Analgesia as Indicated by Pain Score Assessed by Visual Analogue Scale (VAS)
3.5; 2.53
SECONDARY
Success of Analgesia as Indicated by Pain Score Assessed by Visual Analogue Scale (VAS)
3.5; 2.53
SECONDARY
Success of Analgesia as Indicated by Pain Score Assessed by Visual Analogue Scale (VAS)
3.5; 2.53
SECONDARY
Childbirth Experience as Assessed by a Visual Analogue Scale (VAS)
8.25; 9.25
SECONDARY
Maternal Satisfaction as Assessed by a Visual Analogue Scale (VAS)
8.42; 9.25
SECONDARY
Neonatal Outcome as Assessed by (APGAR) Score
8.93; 9.04
SECONDARY
Neonatal Outcome as Assessed by (APGAR) Score
8.93; 9.04
SECONDARY
Time From Regional Anesthesia to Delivery
415.7; 454.5
SECONDARY
Time From Second Stage of Labor to Delivery
71.25; 42.57

Summary

To compare the effects of epidural versus combined spinal and epidural (CSE) anesthesia on the success of Trial of Labor After Cesarean (TOLAC).

Eligibility Criteria

Inclusion Criteria

  • all patients meeting ACOG guidelines for TOLAC
  • at least one previous elective cesarean delivery
  • 40
  • associated comorbidities such as gestational diabetes, preeclampsia, abnormal placentation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02105558). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search